-
patient-derived organoids and immune cell co-culture systems from patients across diverse ancestries. The successful candidate will have access to all of these resources in the Beyaz lab and work in
-
Degradation (TPD) therapeutic strategies to abrogate or rewire cancer cell signaling. We have recently established a new discovery platform to expand the landscape of TPD E3 ligases and targeting modalities
-
and immune cell co-culture systems from patients across diverse ancestries. The successful candidate will have access to all of these resources in the Beyaz lab and work in partnership with our clinical
-
mechanisms, with a track record of creative research in molecular biology, cell biology, genomics, imaging approaches and/or bioinformatics. If selected for this position, you will be expected to: Develop and
-
hematopoietic cell development and hematologic cancers. Based on these basic mechanistic insights, the Laboratory is building innovative therapeutics to treat hematopoietic cancers that are currently without